Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cipla
Cipla
BSE: 500087NSE: CIPLAISIN: INE059A01026

21st-May-2020 08:13Source: BSE

Cipla - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Cipla Limited receives final approval for generic version of Migranal® (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) with a Competitive Generic Therapy Designation

Sections